Gilbert Cisneros Buys Shares of PWP $PWP
Key Points
- Gilbert Cisneros bought Perella Weinberg Partners ($PWP) stock ($1,001 - $15,000).
- The trade was disclosed by a member of the House.
- $PWP last traded around $15.66.
Gilbert Cisneros vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Gilbert Cisneros, a member of the House, bought $1,001 - $15,000 of Perella Weinberg Partners ($PWP) stock on 2026-05-29, according to a periodic transaction report filed under the STOCK Act. Disclosures are filed after the trade and reflect a dollar range, not an exact amount.
Perella Weinberg Partners ($PWP) Stock
Perella Weinberg Partners Earnings
Perella Weinberg Partners Dividend
Analysts Set New Price Targets
About Perella Weinberg Partners
Perella Weinberg Partners, an independent advisory firm, provides strategic and financial advice services in the United States, the United Kingdom, and internationally. It offers advisory services related to strategic and financial decisions, mergers and acquisition execution, shareholder engagement advisory, and financing and capital solutions advice with a focus on restructuring, liability management, capital markets advisory, and private capital placement, as well as underwriting and research services primarily for the energy and related industries. The company serves public multinational corporations, mid-sized public and private companies, financial sponsors, individual entrepreneurs, private and institutional investors, creditor committees, and government institutions in consumer and retail; energy and energy transition; financial services and FinTech; healthcare; industrials and infrastructure; and technology, telecommunication, and media industries. Perella Weinberg Partners is headquartered in New York, New York.
See Also
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.